down arrow

YS Biopharma Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG9845F1090
USD
0.84
0 (-0.02%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Champions Oncology, Inc.
NanoString Technologies, Inc.
Eliem Therapeutics, Inc.
BioAtla, Inc.
BioXcel Therapeutics, Inc.
Jasper Therapeutics, Inc.
YS Biopharma Co. Ltd.
Athira Pharma, Inc.
Turnstone Biologics Corp.
Vaccinex, Inc.
Affimed NV
Why is YS Biopharma Co. Ltd. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is YS Biopharma Co. Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
YS Biopharma Co. Ltd.
-70.53%
-0.62
141.35%
S&P 500
12.66%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.99%
EBIT Growth (5y)
17.07%
EBIT to Interest (avg)
-0.65
Debt to EBITDA (avg)
1.02
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
27.23
Tax Ratio
8.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.50%
ROCE (avg)
0.98%
ROE (avg)
1.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.23
EV to EBIT
20.84
EV to EBITDA
3.60
EV to Capital Employed
0.41
EV to Sales
0.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.96%
ROE (Latest)
-22.61%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is not working for YS Biopharma Co. Ltd.
Interest
At USD 3.27 MM has Grown at 177.26%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."